Are you Dr. Rowbotham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero St
San Francisco, CA 94115Phone+1 415-885-7899Fax+1 415-885-7855
Summary
- Dr. Michael Rowbotham, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with California Pacific Medical Center and UCSF Medical Center.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1986 - 1988
- Boston University Medical CenterResidency, Neurology, 1984 - 1986
- University of California San Francisco School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1981 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Levetiracetam for Treatment of Pain Associated With Fibromyalgia Start of enrollment: 2004 Mar 01
- Naltrexone Effects on Alcohol Intake Start of enrollment: 2005 Feb 01
- Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 407 citationsPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.Leslie J. Crofford, Michael C. Rowbotham, Philip J. Mease, I. Jon Russell, Robert H. Dworkin
Arthritis and Rheumatism. 2005-04-01 - 212 citationsConsiderations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.Robert H. Dworkin, Dennis C. Turk, Sarah Peirce-Sandner, Laurie B. Burke, John T. Farrar
Pain. 2012-06-01 - 2165 citationsPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.Nanna B. Finnerup, Nadine Attal, Simon Haroutounian, Ewan D McNicol, Ralf Baron
The Lancet. Neurology. 2015-02-01
Press Mentions
- Opioid Tolerance, Hyperalgesia Increase Following Stable DosingFebruary 19th, 2020
- CPMC Research Institute Scientific Director Receives Top Accolades from the American Academy of NeurologyApril 14th, 2016
- Making Inroads in Fight Against Shingles PainFebruary 15th, 2000
- Join now to see all
Grant Support
- Chronic Neuropathic Pain Mechanisms And ManagementNational Institute Of Neurological Disorders And Stroke2000–2004
- Pain &Neural Dysfunction From Acute Herpes ZosterNational Institute Of Neurological Disorders And Stroke2000–2002
- Opioid Responsivity/ Analgesic Tolerance In Chronic PainNational Institute Of Neurological Disorders And Stroke2000–2002
- Mechanisms Of Pain And AnalgesiaNational Institute Of Neurological Disorders And Stroke1996–1999
- Opioid Analgesia And Tolerance DevelopmentNational Institute On Drug Abuse1997–1998